Edition:
United Kingdom

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

12.12USD
22 May 2018
Change (% chg)

$-0.07 (-0.57%)
Prev Close
$12.19
Open
$12.23
Day's High
$12.23
Day's Low
$12.12
Volume
3,711
Avg. Vol
135,510
52-wk High
$14.62
52-wk Low
$4.29

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 8.20 -0.037
FY 2017 Dec '17 4.27 -0.049
Sep '17 27.18 -0.002
Jun '17 3.52 -0.036
Mar '17 2.86 -0.051
FY 2016 Dec '16 8.54 -0.036
Sep '16 2.42 -0.044
Jun '16 0.33 -0.052
Mar '16 2.92 -0.037
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 7 8.20 13.00 4.00 5.34
Quarter Ending Sep-18 7 22.01 60.00 4.82 5.34
Year Ending Dec-18 7 45.63 76.00 22.70 26.23
Year Ending Dec-19 7 24.71 65.00 0.00 22.34
Earnings (per share)
Quarter Ending Jun-18 6 -0.28 -0.24 -0.37 -0.29
Quarter Ending Sep-18 6 -0.12 0.29 -0.38 -0.29
Year Ending Dec-18 6 -0.93 -0.46 -1.38 -1.09
Year Ending Dec-19 6 -1.31 -0.93 -1.82 -1.31
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 222.84 32.59
P/E High - Last 5 Yrs. -- 281.48 47.07
P/E Low - Last 5 Yrs. -- 95.47 24.59
Beta -- 0.75 0.79
Price to Sales (TTM) 26.37 262.06 9.01
Price to Book (MRQ) 6.00 23.14 4.24
Price to Tangible Book (MRQ) 5.99 26.27 5.79
Price to Cash Flow (TTM) -- 127.68 21.78
% Owned Institutions 11.19 10.94 2.43

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.66
Dividend Yield - 5 Year Avg -- 0.21 0.80
Dividend 5 Year Growth Rate -- 2.35 4.15
Payout Ratio(TTM) -- 46.91 17.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 186.87 26.86 5.10
Sales (TTM) vs TTM 1 Yr. Ago 205.38 150.04 12.65
Sales - 5 Yr. Growth Rate -- 30.10 8.10
EPS (MRQ) vs Qtr. 1 Yr. Ago 26.19 -158.81 33.25
EPS (TTM) vs TTM 1 Yr. Ago 32.16 -- --
EPS - 5 Yr. Growth Rate -- 46.66 8.54
Capital Spending - 5 Yr. Growth Rate -- 38.70 8.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.64 2.50
Current Ratio (MRQ) 3.77 6.54 3.56
LT Debt to Equity (MRQ) 0.00 22.23 12.86
Total Debt to Equity (MRQ) 0.00 25.74 15.83
Interest Coverage (TTM) -- -177.44 35.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 33.95 54.64
Gross Margin - 5 Yr. Avg. -- 54.86 52.74
EBITD Margin (TTM) -187.44 -- --
EBITD - 5 Yr. Avg -- -158.47 15.84
Operating Margin (TTM) -201.94 -930.08 -2.34
Operating Margin - 5 Yr. Avg. -- -171.29 11.09
Pre-Tax Margin (TTM) -160.03 -814.97 -0.23
Pre-Tax Margin - 5 Yr. Avg. -- -176.85 11.29
Net Profit Margin (TTM) -160.83 -806.24 -3.64
Net Profit Margin - 5 Yr. Avg. -- -176.13 7.58
Effective Tax Rate (TTM) -- 14.58 31.25
Effective Tax Rate - 5 Yr. Avg. -- 18.23 24.61

Efficiency

  Company industry sector
Revenue/Employee (TTM) 116,367 21,442,083 721,262,098
Net Income/Employee (TTM) -187,154 -1,504,037 83,813,821
Receivable Turnover (TTM) 16.74 16.37 5.67
Inventory Turnover (TTM) -- 2.46 3.55
Asset Turnover (TTM) 0.17 0.42 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -27.07 -5.46 9.98
Return on Assets - 5 Yr. Avg. -- -0.52 11.07
Return on Investment (TTM) -32.35 -7.75 12.60
Return on Investment - 5 Yr. Avg. -- 2.72 14.34
Return on Equity (TTM) -34.75 -10.55 14.49
Return on Equity - 5 Yr. Avg. -- -2.70 15.71
  1 Year 3 Year 5 Year
Sales % 166.47 -- --
EPS (TTM) % 21.12 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Adaptimmune Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -0.81 -3.09 41 40
13 Week 41.42 41.37 90 45
26 Week 55.29 46.71 83 84
52 Week 126.16 97.09 88 83
YTD 82.49 78.52 91 81
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.19%
# of Holders: 89
Total Shares Held: 63,225,429
3 Mo. Net Change: 4,184,137
# New Positions: 23
# Closed Positions: 12
# Increased Positions: 49
# Reduced Positions: 34
# Net Buyers: 15
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.